Your browser doesn't support javascript.
loading
No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring System.
Rivière, Pauline; Vermeire, Séverine; Irles-Depe, Marie; Van Assche, Gert; Rutgeerts, Paul; de Buck van Overstraeten, Anthony; Denost, Quentin; Wolthuis, Albert; D'Hoore, Andre; Laharie, David; Ferrante, Marc.
Afiliación
  • Rivière P; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • Vermeire S; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • Irles-Depe M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Van Assche G; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • Rutgeerts P; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • de Buck van Overstraeten A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Denost Q; Department of Abdominal Surgery, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France.
  • Wolthuis A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • D'Hoore A; Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Laharie D; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Ferrante M; Department of Hepatogastroenterology and Digestive Oncology, Haut-Lévêque Hospital, CHU de Bordeaux, Bordeaux, France. Electronic address: marc.ferrante@uzleuven.be.
Clin Gastroenterol Hepatol ; 17(8): 1643-1645, 2019 07.
Article en En | MEDLINE | ID: mdl-30291910
ABSTRACT
The postoperative endoscopic recurrence score, commonly referred to as the Rutgeerts score, was designed to predict clinical recurrence risk in Crohn's disease (CD) patients undergoing ileocolonic resection based on early endoscopic findings at the anastomosis and in the neoterminal ileum.1 In the pivotal publication, the i2 category, including aphthous lesions in the terminal ileum as well as ileocolonic anastomosis lesions, had a heterogeneous recurrence risk. Because anastomotic ulcers were suspected to be postsurgical ischemic lesions and less predictive of progressive disease,2 a modified Rutgeerts score (mRS) was proposed i2a, lesions confined to the anastomosis ±<5 isolated aphthous ulcers in the ileum; i2b, more than 5 aphthous ulcers in the ileum with normal mucosa in between, ± anastomotic lesions.3,4.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Colonoscopía / Colectomía / Íleon Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Colonoscopía / Colectomía / Íleon Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Francia